Equity Research, Broker Reports, and media content on PFIZER INC

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about PFIZER INC
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on PFIZER INC. We currently have 0 research reports from 0 professional analysts.

Date Source Announcement
01Dec16 01:45 PRN Biotech Sector Growth Expected Upon Diminishing Concerns Over Drug Pricing
01Dec16 01:00 PRN IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery
30Nov16 09:01 PRN Omnicell's Performance Center Integrates with Hospira's Infusion Pump Software
29Nov16 01:21 PRN FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review
29Nov16 01:17 PRN FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review
28Nov16 01:30 PRN Innovative Clinical Trial Implementation and Manufacturing Capacity Production Fueling Biotech Sector Growth
10Nov16 02:31 PRN First Majestic Silver trade offers a 2.42% return in 71 days, or find similar option trades on SPDR Gold Trust, Ralph Lauren, Pfizer Inc., and Magellan Health Inc.
  • Frequency of research reports

     

  • Research reports on

    PFIZER INC

  • Providers covering

    PFIZER INC